These lab-designed choices were not developed with recreational use in mind. Inside the 1990s, John W. Huffman in addition to a staff of fellow chemists at Clemson University produced some of the initial formulation for synthetic cannabinoid receptor agonists (SCRAs), a household of substances that imitate the physiological and psychological impact